bmy bristol myers squibb

News

Bristol Myers Squibb Cuts Full-Year Adjusted View

Bristol Myers Squibb Cuts Full-Year Adjusted View, but Raises Revenue Expectations

Bristol Myers Squibb trimmed its full-year adjusted earnings view as it reported lower second-quarter earnings due to a charge related to its BioNTech partnership.

Reuters on MSN · 19h

Bristol Myers tops revenue expectations on strength of older drugs, shares fall

Bristol Myers Squibb posted much better-than-expected second-quarter results on Thursday on strong sales of its best-selling brands, but failed to convince investors that newer products could drive future growth and shares fell nearly 5%.

StockStory.org on MSN · 2d

Bristol-Myers Squibb (BMY) Q2 Earnings: What To Expect

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be reporting results this Thursday morning. Here’s what you need to know. Bristol-Myers Squibb beat analysts’ revenue expectations by 3.9% last quarter,

17h

Why Bristol-Myers Squibb (BMY) Stock Is Trading Lower Today

Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) fell 4.2% in the afternoon session after the company ...

15h

Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors

Shares of Bristol Myers Squibb Co. BMY slid 5.81% to $43.31 Thursday, on what proved to be an all-around dismal trading ...

8hon MSN

Bristol-Myers Squibb (BMY) Sees Healthy Momentum in Growth Portfolio in Q2 2025

Bristol-Myers Squibb Company (NYSE:BMY) is one of the Best 52-Week Low Blue Chip Stocks to Buy Now. On July 31, the company reported results for Q2 2025, wherein it saw healthy momentum throughout its ...

20h

Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q2, Full-Year Sales Guidance is Optimistic

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced better-than-expected revenue in Q2 CY2025, but sales were ...

1don MSN

Bristol-Myers delivers double beat and raises full-year sales forecast

Bristol-Myers Squibb (BMY) shares rise after beating Q2 forecasts, raising 2025 revenue outlook, and showcasing growth in key ...

15h

2BMY : Bristol-Myers Squibb Unusual Options Activity For July 31

Out of all of the special options we uncovered, 26 are puts, for a total amount of $1,771,839, and 16 are calls, for a total amount of $839,064. Taking into account the Volume and Open Interest on ...

2don MSN

Bristol Myers, Bain Capital form new company to develop immunology drugs

Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors

This was the stock's fifth consecutive day of losses.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results